INNV InnovAge Holding Corp.

InnovAge Holding (INNV) completed a US$92.5m follow-on equity offering of 10,000,000 common shares on 22 September 2026, pricing the new stock at US$9.25 with a US$0.4625 discount per share. InnovAge Holding’s latest US$9.00 share price comes after a 1-day share price return of 1.81%, but the stock is down 17.13% over 30 days and 22.48% over 90 days, even with a 73.41% year-to-date share price return and 87.5% 1-year total shareholder return that hint at earlier momentum cooling as investors...

Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

InnovAge Holding Corp. (NASDAQ:INNV) reported fiscal 2026 revenue of $989.7 million on September 8, up 15.9%. Company-defined non-GAAP adjusted EBITDA reached $94.6 million, versus $34.5 million a year earlier. The measure adjusts net income or loss for net interest, investment income, taxes, depreciation and amortization, stock compensation, losses on cost and equity-method investments, and specified […]

Adjusted EBITDA surged 174% despite litigation accruals impacting net income.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.4% and the actively tr

Moby summary of InnovAge Holding Corp.'s Q4 2026 earnings call

Adjusted EBITDA surges 175% in fiscal 2026 as the company outlines a disciplined path to 10%+ margins amid a tempered 2027 rate environment.

InnovAge (NASDAQ:INNV) reported fiscal 2026 revenue growth, higher census and a sharp increase in adjusted EBITDA as the provider of Program of All-Inclusive Care for the Elderly, or PACE, services said it has moved beyond a multiyear operational turnaround and is focusing on scalable growth. For t

InnovAge (INNV) delivered earnings and revenue surprises of -33.33% and +9.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

InnovAge (INNV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HealthEquity (HQY) delivered earnings and revenue surprises of +4.20% and +0.14%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Motion Acquisition (DCGO) delivered earnings and revenue surprises of +500.00% and -2.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MDxHealth SA (MDXH) delivered earnings and revenue surprises of -50.00% and +5.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Sera Prognostics (SERA) delivered earnings and revenue surprises of -28.57% and -76.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?